Short interest in Beam Therapeutics Inc (NASDAQ:BEAM) increased during the last reporting period, rising from 11.16M to 12.31M. This put 19.57% of the company's publicly available shares short.

Short interest for Beam Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Beam Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 1.13M shares traded per day, it would take 10.91 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.